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Edited by Angel NebredaAbstract Electrical stimulation of the vagal eﬀerent nerve im-
proves the survival of myocardial infarcted rats. However, the
mechanism for this beneﬁcial eﬀect is unclear. We investigated
the eﬀect of acetylcholine (ACh) on hypoxia-inducible factor
(HIF)-1a using rat cardiomyocytes under normoxia and hypox-
ia. ACh posttranslationally regulated HIF-1a and increased its
protein level under normoxia.ACh increasedAkt phosphorylation,
and wortmannin or atropine blocked this eﬀect. Hypoxia-induced
caspase-3 activation and mitochondrial membrane potential col-
lapse were prevented by ACh. Dominant-negative HIF-1a inhib-
ited the cell protective eﬀect of ACh. In acute myocardial
ischemia, vagal nerve stimulation increased HIF-1a expression
and reduced the infarct size. These results suggest that ACh
and vagal stimulation protect cardiomyocytes through the
PI3K/Akt/HIF-1a pathway.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The prognosis of patients with chronic heart failure remains
poor, due to progressive remodeling of the heart and lethal
arrhythmia. Acute ischemia or hypoxia causes loss of cardio-
myocytes, followed by remodeling in the chronic phase.
Although various therapeutic approaches have been intro-
duced, including implantable deﬁbrillators [1], a more eﬀective
modality of therapy has been anticipated for several years. A
recent animal study by Li et al. [2] demonstrated that vagal
nerve stimulation prevented ventricular remodeling after myo-
cardial infarction, suggesting a novel therapeutic strategy
against heart failure. Furthermore, Krieg et al. [3] reported
that acetylcholine (ACh) has a cardioprotective eﬀect.
Although nitric oxide (NO) is supposed to be a major signaling
molecule induced by ACh, a mechanism for the beneﬁcial ef-
fect of vagal nerve stimulation on cardiomyocytes remains to
be clariﬁed. To investigate this mechanism, we hypothesized
that vagal stimulation or ACh directly triggers a cell survival
signal that is subsequently ampliﬁed and leads to protection
of the cardiomyocytes from acute ischemic conditions, and*Corresponding author. Fax: +81 88 880 2310.
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doi:10.1016/j.febslet.2005.02.065that this eﬀect of ACh, if continued, could be responsible for
chronic cardioprotection.
In the present study, we focused on demonstrating the cellu-
lar action of ACh through hypoxia-inducible factor (HIF)-1a.
HIF-1a is a transcription factor that is important for cell sur-
vival under hypoxia. HIF-1a activates the expression of many
genes indispensable for cell survival [4,5]. Under normoxia, the
HIF-1a protein level is very low, due to proteasomal degrada-
tion through with von Hippel–Lindau tumor suppressor pro-
tein (VHL). However, HIF-1a escapes from this degradation
under hypoxia, and this is recognized as the hypoxic pathway
[6,7]. Recently, it was revealed that HIF-1a can be also in-
duced via a non-hypoxic pathway by angiotensin II [8,9]. Ta-
ken together, it is conceivable that HIF-1a induction is one
of the adaptation processes to hypoxia and ischemia, and that
additional induction of HIF-1a during ischemia via a non-hyp-
oxic pathway could provide further cardioprotection.
Therefore, we investigated the direct eﬀects of ACh on sur-
vival signaling in cardiomyocytes and of vagal stimulation
on hearts. The results suggest that ACh and vagal stimulation
protect cardiomyocytes from acute hypoxia and ischemia via
additional HIF-1a protein induction through a non-hypoxic
pathway.2. Materials and methods
2.1. Cell culture
To examine the eﬀect of ACh on cardiomyocytes, H9c2 cells as well
as primary cardiomyocytes isolated from neonatal rats were used.
H9c2 cells, which are frequently used to investigate signal transduction
and channels in rat cardiomyocytes, are derived from rat embryonic
ventricular cardiomyocytes. H9c2 cells were incubated in Dulbeccos
modiﬁed Eagles medium (DMEM) containing 10% fetal bovine serum
(FBS) and antibiotics. Primary cardiomyocytes were isolated from 2–
3-day-old neonatal WKY rats and incubated in DMEM/Ham F-12
containing 10% FBS. HEK293 cells and HeLa cells cultured in
DMEM containing 10% FBS were also used.
2.2. Western Blot analysis
H9c2 cells and primary cardiomyocytes were treated with 1 mM
ACh to evaluate expression of HIF-1a protein under normoxia or with
1 mM S-nitroso-N-acetylpenicillamine (SNAP) to study the signal
transduction. To investigate the signal transduction, H9c2 cells were
pretreated with a PI3K inhibitor, (wortmannin; 300 nM), a muscarinic
receptor, (atropine; 1 mM), a transcriptional inhibitor, (actinomycin
D; 0.5 lg/ml) or a protein synthesis inhibitor, (cycloheximide; 10 lg/
ml), followed by ACh treatment. Cell lysates were mixed with a sampleblished by Elsevier B.V. All rights reserved.
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branes. The membranes were incubated with primary antibodies
against HIF-1a (Santa Cruz Biotechnology, Santa Cruz, CA, USA),
Akt and phospho-Akt (Cell Signaling Technology, Beverly, MA,
USA), and a-tubulin (Lab Vision, Fremont, CA, USA), and then re-
acted with an HRP-conjugated secondary antibody (BD Transduction
Laboratories, San Diego, CA, USA). Positive signals were detected
with an enhanced chemiluminescence system (Amersham, Piscataway,
NJ, USA). In each study, the experiments were performed in duplicate
and repeated 3–5 times (n = 3–5). Representative data are shown.
2.3. MTT activity assay
To evaluate the eﬀects of hypoxia and ACh on the mitochondrial
function of cardiomyocytes, we measured 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction activity in
H9c2 or HEK293 cells under hypoxia (1% oxygen concentration), in
the presence or absence of ACh. The cells were pretreated with
1 mM ACh for 12 h, and then subjected to hypoxia for 12 h. At 4 h
before sampling, the MTT reagents were added to the culture and
incubated.2.4. Caspase-3 activity assay
Caspase-3 activity was measured using a CPP32/Caspase-3 Fluoro-
metric Protease Assay Kit, (Chemicon International, Temecula, CA,
USA). Hypoxia-treated H9c2 cells with or without 1 mM ACh pre-
treatment were lysed and the cytosolic extract was added to the cas-
pase-3 substrate. A ﬂuorometer equipped with a 400-nm excitation
ﬁlter and 505-nm emission ﬁlter was used to measure the samples.2.5. DePsipher assay
To examine the eﬀects of hypoxia and ACh on the mitochondrial
electrochemical gradient, we analyzed cardiomyocytes using a DePsi-
pher
TM
Mitochondrial Potential Assay Kit (Trevigen, Gaithersburg,
Maryland, USA). Apoptotic cells, which undergo mitochondrial mem-Fig. 1. HIF-1a is induced by ACh in rat cardiomyocytes even under normoxia
protein level is increased (#P < 0.05 vs. control, n = 4). (B) ACh (1 mM) inc
n = 3).brane potential collapse cannot accumulate the DePsipher reagent in
their mitochondria. As a result, apoptotic cells show decreased red
ﬂuorescence in their mitochondria, and the reagent remains in the
cytoplasm as a green ﬂuorescent monomer. Therefore, apoptotic cells
were easily diﬀerentiated from healthy cells, which showed more red
ﬂuorescence.
2.6. Evaluation of NO production
NO production was measured using the 4,5-diaminoﬂuoresceindiac-
etate (DAF-2DA; Alexis, Lausen, Switzerland) ﬂuorometric NO detec-
tion system as previously reported [10]. The intensity of the DAF-2DA
green ﬂuorescence in ACh-treated cells was measured and compared
with that in non-treated cells (kEx 492 nm; kEm 515 nm).2.7. Transfection
To investigate the direct contribution of Akt phosphorylation to
HIF-1a stabilization or that of HIF-1a to the ACh eﬀect, HEK293
cells were transfected with an expression vector for wild-type Akt
(wt Akt), dominant-negative Akt (dn Akt) [11], wild-type HIF-1a
(wt HIF-1a) [12] or dominant-negative HIF-1a (dn HIF-1a), using
Eﬀectene (Qiagen, Valencia, CA, USA) according to the manufactures
protocol. After transfection, HEK293 cells were pretreated with 1 mM
ACh for 12 h, followed by evaluating the HIF-1a protein level or by
hypoxia for 12 h and MTT activity in each group was evaluated. As
a control, cells were transfected with a vector for green ﬂuorescent
protein (GFP).2.8. RT-PCR
Total RNA was isolated from H9c2 cells according to a modiﬁed
acid guanidinium–phenol–chloroform method using an RNA isolation
kit (ISOGEN; Nippon Gene, Tokyo, Japan), and reverse-transcribed
to obtain a ﬁrst-strand cDNA. This ﬁrst-strand cDNA was ampliﬁed
by speciﬁc primers for HIF-1a, and the PCR products were fraction-
ated by electrophoresis.. (A) After treatment of H9c2 cells with 1 mMACh for 8 h, the HIF-1a
reases the intensity of DAF-2DA ﬂuorescence (#P < 0.01 vs. control,
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Left ventricular myocardial ischemia (MI) was performed by 3 h of
left coronary artery (LCA) ligation in anesthetized 9-week-old male
Wistar rats under artiﬁcial ventilation previously described [2].
Sham-operated (control) rats did not undergo LCA ligation. For vagal
nerve stimulation (VS), the right vagal nerve in the neck was isolated
and cut. Only the distal end of the vagal nerve was stimulated in order
to exclude the eﬀects of the vagal aﬀerent. The electrode was connected
to an isolated constant voltage stimulator. VS was performed from
1 min before the LCA ligation until 3 h afterwards, using 0.1 ms pulses
at 10 Hz (MI-VS). The electrical voltage of the pulses was adjusted to
obtain a 10% reduction in the heart rate before LCA ligation, but VS
(MI-VS) was not associated with any blood pressure reduction during
the experiments, compared with MI. At the end of the experiments, the
rats were either injected with 2 ml of 2% Evans blue dye via the femoral
vein to measure the risk area followed by determination of the infarct
size with 2% triphenyl tetrazolium chloride (TTC) staining or the heart
was excised for protein isolation and subsequent Western Blotting to
detect HIF-1a protein. The percentage of the infarcted area of the left
ventricle was calculated as the ratio of the infarcted area to the risk
area.Fig. 2. HIF-1a induction by ACh is posttranslationally regulated in rat cardi
in the presence of 0.5 lg/ml of actinomycin D is increased by 1 mM ACh to
signiﬁcant, n = 3). (B) Actinomycin D does not decrease the HIF-1a mRNA
aﬀect the HIF-1a protein level (n = 3).
Fig. 3. Rat primary cultured cardiomyocytes show comparable HIF-1a indu2.10. Densitometry
The Western Blotting data were analyzed using Kodak 1D Image
Analysis Software (Eastman Kodak Co., Rochester, NY, USA).
2.11. Statistics
The data were presented as means ± S.E. The mean values between
two groups were compared by the unpaired Students t test. Diﬀerences
among data were assessed by ANOVA for multiple comparisons of re-
sults. Diﬀerences were considered signiﬁcant at P < 0.05.3. Results
3.1. Posttranslational regulation of HIF-1a by ACh through a
non-hypoxic pathway
ACh (1 mM) increased HIF-1a protein expression in H9c2
cells under normoxia (Fig. 1A). ACh increased NO produc-
tion, as evaluated by DAF-2DA (Fig. 1B), suggesting thatomyocytes under normoxia. (A) The HIF-1a protein level in H9c2 cells
a comparable level to that in the absence of actinomycin D (N.S., not
level, as evaluated by RT-PCR. (C) Cycloheximide (10 lg/ml) does not
ction by 1 mM ACh to that in H9c2 cells (#P < 0.05 vs. control, n = 3).
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Actinomycin D (0.5 lg/ml; Figs. 2A and B) and cycloheximide
(10 lg/ml; Fig. 2C) did not decrease theHIF-1a level under nor-
moxia, suggesting thatHIF-1adegradation is regulated byACh.
Furthermore, ACh increased HIF-1 a level in primary cardio-
myocytes without reducing their beating rate (Fig. 3). Since
H9c2 cells did not beat, these results suggest that HIF-1 induc-
tion is independent of the heart rate-decreasing eﬀect of ACh.Fig. 4. Akt is activated by ACh in rat cardiomyocytes, leading to HIF-1a in
1 mM ACh (#P < 0.05 vs. baseline, n = 4), whereas the total protein leve
phosphorylation is blocked by 1 mM atropine (#P < 0.05 vs. 0 lM atropin
primary cardiomyocytes (#P < 0.05 vs. baseline, n = 3), and atropine block
inhibits ACh-induced Akt phosphorylation in H9c2 cells (N.S., not signiﬁcan
ACh (#P < 0.05 vs. wortmannin (+), n = 3). Each ﬁgure shows a representativ
contrast to wt Akt, HIF-1a induction by ACh is blocked by dn Akt in HEK3.2. Akt phosphorylation by ACh
ACh had no eﬀect on the total Akt protein level, but in-
creased Akt phosphorylation (Fig. 4A) as eﬀectively as SNAP
(data not shown). The ACh-induced Akt phosphorylation was
inhibited by atropine in a dose-dependent manner (Fig. 4B).
ACh-induced Akt phosphorylation and its inhibition by
atropine were also observed in rat primary cardiomyocytes
(Fig. 4C).duction. (A) Akt phosphorylation in H9c2 cells is rapidly increased by
l of Akt remains unaﬀected. (B) The ACh-induced increase in Akt
e, n = 3). (C) ACh (1 mM) also increases Akt phosphorylation in rat
s this eﬀect. (D) Pretreatment with 300 nM wortmannin completely
t, n = 3). (E) Wortmannin (300 nM) also inhibits HIF-1a induction by
e result from three independently performed experiments (n = 3). (F) In
293 cells (n = 4).
Fig. 4 (continued)
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Wortmannin completely inhibited the ACh-induced Akt
phosphorylation (Fig. 4D), in clear contrast to the data in
Fig. 4A. Furthermore, it also attenuated the HIF-1a induction
by ACh (Fig. 4E). To elucidate the contribution of Akt phos-
phorylation to HIF-1a protein level in normoxia, dn Akt was
introduced into HEK293 cells, and found to partially inhibit
the HIF-1a induction by ACh (Fig. 4F).
3.4. Eﬀect of ACh on apoptosis during hypoxia
The DePsipher assay clearly showed that hypoxia (1% oxy-
gen concentration) for 12 h caused mitochondrial membrane
potential collapse leading to cell death, and that 1 mM ACh
inhibited this collapse in H9c2 cells (Fig. 5A). ACh attenuated
the decrease in MTT activity caused by 12 h of hypoxia in
H9c2 cells (Fig. 5B; 103.4 ± 0.8% in ACh + hypoxia vs.
56.6 ± 0.7% in hypoxia, P < 0.01, n = 8) and HEK293 cells
(P < 0.01 vs. hypoxia). The caspase-3 activity was increased
by hypoxia in H9c2 cells, and pretreatment with 1 mM ACh
inhibited this increase (Fig. 5C; 128 ± 2% in hypoxia vs.
90 ± 2% in ACh + hypoxia, P < 0.01, n = 4). To elucidate the
dependency of the ACh-induced protective eﬀect on HIF-1a,
dn HIF-1a was transfected into HEK293 cells, followed by
ACh pretreatment and then hypoxia. It was found that dn
HIF-1a inhibited the protective eﬀect of ACh from hypoxia
(Fig. 5D; 115.1 ± 1.2% in wt HIF-1a and 111.8 ± 1.8% in
GFP vs. 59.0 ± 3.4% in dn HIF-1a, P < 0.05, n = 10), suggest-
ing that HIF-1a induction by ACh is partially responsible for
the protective eﬀect.
3.5. Eﬀect of vagal stimulation on HIF-1a in myocardial
ischemia
To evaluate the signiﬁcance of ACh for cardioprotection in
vivo, the vagal nerve was stimulated prior to the MI. Histolog-
ical analysis demonstrated a tendency for the infarcted areafrom the vagal nerve-stimulated (MI-VS) hearts to be smaller
than that from non-stimulated (MI) hearts (31.5 ± 4.6% in
MI-VS vs. 40.9 ± 2.5% in MI, n = 3), even though the risk
areas (non-perfused areas) were comparable (Fig. 6A;
59.2 ± 1.0% in MI-VS vs. 53.7 ± 1.0% in MI, n = 3). In the
MI-VS hearts, the HIF-1a protein level was further elevated
compared to that in the MI hearts (Fig. 6B; 244 ± 24% in
MI-VS vs. 112 ± 1% in MI, n = 3). These results suggest that
vagal nerve stimulation in the ischemic heart activates both
the hypoxic and non-hypoxic pathways of HIF-1a induction,
resulting in increased induction of HIF-1a.
3.6. Non-hypoxic induction of HIF-1a in other cells
The observed ACh-mediated HIF-1 induction was not lim-
ited to H9c2 or primary cultured cardiomyocytes, but also
found in several other types of cell lines, including HEK293,
and HeLa cells (Fig. 7). Since these cells did not beat sponta-
neously, the results suggest that the system of ACh-mediated
HIF-1a induction is not only independent of the beating rate
of cardiomyocytes, but also a generally conserved system in
cells.4. Discussion
4.1. Cardioprotective action by ACh and vagal stimulation via
the muscarinic receptor
Using animal models, several studies have shown that accen-
tuated antagonism against the sympathetic nervous system is a
major mechanism for the beneﬁcial eﬀect of vagal tone on the
ischemic heart [13]. Although ACh was involved in triggering
preconditioning mechanisms in an ischemia-reperfusion model
[3], it remained unclear whether vagal nerve stimulation in
acute ischemia or hypoxia followed these mechanisms. In
the present study, we have disclosed that ACh possesses a
2116 Y. Kakinuma et al. / FEBS Letters 579 (2005) 2111–2118protective eﬀect on cardiomyocytes. In rat cardiomyocytes,
ACh triggered a sequence of survival signals through Akt that
eventually induced HIF-1a, inhibited the collapse of the mito-
chondrial membrane potential and decreased caspase-3 activ-
ity, thereby leading to the survival of cardiomyocytes under
hypoxia. Furthermore, our results suggest ACh exerts this ac-
tion through Akt in other cells. The current study therefore
provides another insight into the cellular mechanism for the
cardioprotective eﬀects of ACh and vagal stimulation.Fig. 5. Collapse of the mitochondrial membrane potential in rat cardiomyo
decreases the mitochondrial membrane potential in H9c2 cells within 12 h. R
ACh for 12 h inhibits this eﬀect. (B) Pretreatment with 1 mM ACh inhibits t
only in H9c2 cells (#P < 0.01 vs. hypoxia, n = 8) but also in HEK293 cells (\
whereas pretreatment with 1 mM ACh inhibits this eﬀect (#P < 0.01 vs. hyp
decreases the MTT activity under hypoxia after ACh treatment (#P < 0.01 v4.2. Signaling pathway of ACh via PI3K/Akt and antiapoptotic
eﬀects of ACh
Since previous studies demonstrated that a PI3K inhibitor
greatly reduced HIF-1a induction in heart and renal cells
[14,15] and a few studies have reported that MAP kinase is
activated through ACh, we focused on the PI3K/Akt pathway,
one of the important cell survival signaling pathways [16], and
found that ACh directly activated Akt phosphorylation via
PI3K. PI3K/Akt signaling has been reported to have ancytes under hypoxia is attenuated by ACh pretreatment. (A) Hypoxia
ed spots are decreased by hypoxia, whereas pretreatment with 1 mM
he decrease in MTT reduction activity induced by 12 h of hypoxia not
P < 0.01 vs. hypoxia, n = 8). (C) Hypoxia increases caspase-3 activity,
oxia, n = 3). (D) In contrast to wt HIF-1a or GFP, dn HIF-1a alone
s. wt and GFP, \P < 0.05 vs. non-transfection, n = 10).
Fig. 6. Vagal nerve stimulation decreases infarcted area with increased
HIF-1a expression. (A) A quantitative analysis reveals comparable
non-perfused areas in both vagal-stimulated (MI-VS) and non-
stimulated (MI) hearts, whereas the infarcted area identiﬁed by TTC
staining is smaller in the MI-VS heart than in the MI heart. (B) HIF-1a
induction in the ischemic heart is increased by vagal stimulation (MI-
VS) compared with that in ischemia alone (MI) (#P < 0.01 vs. MI)
(n = 3).
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tion of Bad-binding to Bcl-2, caspase 9, Fas and glycogen syn-
thetase kinase-3 [17,18]. These facts imply a deﬁnite
involvement of Akt activation in cell survival. As shown using
dn HIF-1a, ACh inhibited hypoxia-induced cell death through
HIF-1a induction via Akt phosphorylation. These results indi-
cate that ACh actually protects cardiomyocytes from hypoxia
at the cellular level.Fig. 7. HIF-1a is induced by ACh under normoxia in other cells. ACh
(1 mM) increases HIF-1a protein level in HEK293 and HeLa cells
(n = 3 each) under normoxia.4.3. Additional induction of HIF-1a by ACh and vagal
stimulation
HIF-1a regulates the transcriptional activities of very di-
verse genes involved in cell survival and is itself regulated
at the posttranslational level by VHL [4,6,7]. Recent studies
have shown that HIF-1a is also regulated through a non-
hypoxic pathway involving angiotensin II, TNF-a and NO
[8,9,19,20]. Therefore, it is speculated that cardiomyocytes
possess a similar system for regulating HIF-1a through
ACh, independent of the oxygen concentration. Induction
of HIF-1a is a powerful cellular response against hypoxia,
and further increases in its expression by other pathways
may be beneﬁcial. The present results indicate that the sig-
niﬁcance of ACh or vagal nerve stimulation in hypoxic
stress can be attributed to additional HIF-1a induction
through dual induction pathways, i.e., hypoxic and non-hyp-
oxic pathways.
The present study has revealed that ACh-mediated HIF-1a
induction is widely conserved in other cells. Consistent with
a previous report [10], the current results suggest that NO is
produced by ACh. According to a report that NO attenu-
ates the interaction between pVHL and HIF-1a through
inhibiting PHD activity [21], it is possible that ACh may in-
crease the HIF-1a protein level through NO. Recent studies
conducted by Krieg et al. [3] and Xi et al. [22], have pro-
vided supportive data compatible with our results, while an-
other study by Hirota et al. [23] also revealed a non-hypoxic
pathway for HIF-1a induction by ACh in a human kidney-
derived cell line.
The signaling pathway of the muscarinic receptor has been
studied extensively, and many pathways are involved in its spe-
ciﬁc biological eﬀects. Therefore, possible involvement of other
pathways in the non-hypoxic induction of HIF-1a cannot be
excluded. However, it was demonstrated that dn Akt and dn
HIF-1a decreased the eﬀect of ACh. Consistent with a recent
study [24], we have revealed that ACh or vagal stimulation
protects cardiomyocytes in the acute phase. This observation
suggests that the protective eﬀect in the acute phase may result
in inhibition of cardiac remodeling in the chronic phase, since
vagal stimulation produces additional HIF-1a induction
through a non-hypoxic pathway, which increases cell survival.
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